Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early treatment of patients with central serous retinopathy
2009-017959-98Phase 4Completed
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Dec 2009
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of verteporfin in Central Serous Chorioretinopathy (CSCR) (2 arms), sponsored by Het Oogziekenhuis Rotterdam. Primary endpoint: Visual acuity (BCVA ETDRS) at one year. Started Dec 2009; status: completed.
02
Drugs
verteporfin
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on 2009-017959-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017959-98.